ARTICLE | Clinical News
FGF-1: Phase II started
September 15, 2008 7:00 AM UTC
The company began an open-label, dose-escalation, international Phase II trial to evaluate FGF-1 injected directly into the hearts of 120 patients with stable angina who were not suitable candidates f...